Blog

The Market Changes Daily

We help you stay one step ahead.

Authorized Generics Explained

Designed to stifle competition and circumvent rebate deals with Pharmacy Benefit Managers, authorized generics are one of the most profitable market sectors for drug makers, returning $50 for every $1 invested.

read more

A Brave (Expensive) New World for Payers

The questions of how expensive gene therapies are going to be covered, who will be paying for them, and how our healthcare system can adapt to support getting these cures to those who desperately need them – are not easy questions – but everyone, including the drug companies, are asking them.

read more

The Latest on Drug Patent Scams

The U.S. patent system not only allows but also incentivizes anti-competitive practices, driving up costs for everybody—patients, government payers, and insurers—while at the same time stifling the innovation that high drug prices are supposed to fund.

read more

Generic Drugmakers Are in Big Trouble

A major lawsuit accuses generic drug makers of a price-fixing conspiracy and “billions of dollars of damage” to the US economy… Proof once again that generics now require as much (if not more) vigilance from payers as do brand-name drugs.

read more

About the CVS E-Prescription Initiative

Don’t forget that pricing varies from pharmacy to pharmacy—sometimes dramatically. Scripta ensures that patients know where to shop for the best price for a given medication, even if that is at Walmart or other CVS competitors.

read more

Empathy Is a Healthy Workforce

Most executives agree that business success is tied to empathy in the workplace. Scripta offers companies one more way to show that they care. Most any HR professional will tell you that skyrocketing healthcare and prescription drug prices are necessarily complicating...

read more

PBMs Are Not Saving Anyone Money

It’s not insurers or Big Pharma sustaining rising prescription drug prices—it’s PBMs that are supposed to be saving patients and self-funded insurers money. Stop me if you’ve heard this one before—PBMs insist that drug prices would be even higher without them. Since...

read more

Pharmacy Data Analytics Can Help You SAVE

March 7, 2018 – If you are trying to control health benefits costs, the best place to start is with the data — and good pharmacy data analytics can improve plan design and save money. With the Benefits Pro Broker Expo due up next week in San Diego, we thought we’d...

read more

DUEXIS: The Cost of Convenience

Did you know: Back in 2011, Horizon Pharma introduced a new, nonsteroidal anti-inflammatory drug with built-in stomach protection: DUEXIS. DUEXIS is ibuprofin (generic Motrin) 800mg plus famotidine (generic Pepcid) 26.6mg in one convenient tablet. It's meant to be...

read more

Old made new again (AGAIN)!

Did you know: Generic Paxil - paroxitine hydrochloride - has been available on the $4 plans for some time. We now have Pexeva, which is paroxitine mesylate. What's the difference? Clinically, I am not sure. The NIH, via Pub Med Health, groups it all as paroxitine. The...

read more